Dissecting the role of inflammatory biomarkers in breast cancer: Insights from Mendelian randomization
Open Access
- 15 August 2025
- journal article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (33) , e43732
Abstract
Inflammatory biomarkers (including C-reactive protein [CRP], interleukin-6 [IL-6], procalcitonin [PCT], and serum amyloid A [SAA]) have been postulated to influence tumorigenesis, yet their causal relevance to breast cancer (BC) remains uncertain. We applied a two-sample Mendelian randomization (MR) framework to evaluate putative causal relationships between these circulating inflammatory factors and BC risk. Publicly available genome-wide association study summary statistics were used to identify, curate, and clump single-nucleotide polymorphisms that robustly trace CRP, IL-6, PCT, and SAA concentrations, which then served as instrumental variables. Causal estimates were generated with inverse-variance weighting, MR-Egger regression, weighted-median, simple-mode, and weighted-mode models. Heterogeneity was assessed by Cochran Q statistic, horizontal pleiotropy by the MR-Egger intercept, and robustness by leave-one-out as well as funnel-plot inspection. Two-sample MR demonstrated that genetically predicted SAA is positively associated with BC risk (inverse-variance weighting odds ratios = 1.002, 95% confidence interval 1.000–1.003, P = .023), whereas CRP, IL-6, and PCT exhibited no evidence of causal effects on BC in any MR model. Sensitivity analyses showed no substantial heterogeneity or directional pleiotropy, and causal estimates were stable after sequential SNP exclusion. In summary, the present MR study provides genetic evidence that elevated SAA causally increases the risk of developing BC, whereas CRP, IL-6, and PCT do not appear to exert independent causal influences.Keywords
This publication has 25 references indexed in Scilit:
- Women at high risk of breast cancer: Molecular characteristics, clinical presentation and managementThe Breast, 2016
- From Inflammation to Prostate Cancer: The Role of InflammasomesAdvances in Urology, 2016
- Diagnostic importance of S100A9 and S100A12 in breast cancerBiomedicine & Pharmacotherapy, 2015
- Paired measurement of serum amyloid A (SAA) and paraoxonase 1 (PON1) as useful markers in breast cancer recurrenceClinical Biochemistry, 2015
- Mendelian randomization: genetic anchors for causal inference in epidemiological studiesHuman Molecular Genetics, 2014
- Analysis of acute‐phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancerInternational Journal of Cancer, 2011
- Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort studyBreast Cancer Research, 2011
- Identification and Validation of SAA as a Potential Lung Cancer Biomarker and its Involvement in Metastatic Pathogenesis of Lung CancerJournal of Proteome Research, 2011
- Mendelian Randomization for Strengthening Causal Inference in Observational StudiesPerspectives on Psychological Science, 2010
- Inflammation: A driving force speeds cancer metastasisCell Cycle, 2009